[go: up one dir, main page]

AU2814897A - Method of isolating regulators of t cell activation - Google Patents

Method of isolating regulators of t cell activation

Info

Publication number
AU2814897A
AU2814897A AU28148/97A AU2814897A AU2814897A AU 2814897 A AU2814897 A AU 2814897A AU 28148/97 A AU28148/97 A AU 28148/97A AU 2814897 A AU2814897 A AU 2814897A AU 2814897 A AU2814897 A AU 2814897A
Authority
AU
Australia
Prior art keywords
regulators
isolating
cell activation
activation
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28148/97A
Inventor
Andreas G. Batzer
Augustine Y.-T. Lin
Scott W. Umlauf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
T Cell Sciences Inc
Original Assignee
T Cell Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T Cell Sciences Inc filed Critical T Cell Sciences Inc
Publication of AU2814897A publication Critical patent/AU2814897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU28148/97A 1996-04-25 1997-04-25 Method of isolating regulators of t cell activation Abandoned AU2814897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63928696A 1996-04-25 1996-04-25
US08639286 1996-04-25
PCT/US1997/007052 WO1997039722A2 (en) 1996-04-25 1997-04-25 Method of isolating regulators of t cell activation

Publications (1)

Publication Number Publication Date
AU2814897A true AU2814897A (en) 1997-11-12

Family

ID=24563494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28148/97A Abandoned AU2814897A (en) 1996-04-25 1997-04-25 Method of isolating regulators of t cell activation

Country Status (2)

Country Link
AU (1) AU2814897A (en)
WO (1) WO1997039722A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650714A1 (en) * 1996-12-06 1998-06-10 Melchner Harald Von Prof Dr Gene trap construct for the identification and isolation of genes
US5994507A (en) * 1997-12-31 1999-11-30 Amersham Pharmacia Biotech Ab Method for binding albumin and means to be used in the method
EP1041144B1 (en) * 1999-03-29 2004-06-23 Michael Blind Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
US7541184B2 (en) 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US7572631B2 (en) 2000-02-24 2009-08-11 Invitrogen Corporation Activation and expansion of T cells
AU2001251612A1 (en) * 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
WO2004029620A2 (en) * 2002-09-26 2004-04-08 Novartis Ag Screening method involving transfected primary t cells
AU2003304486A1 (en) * 2003-09-26 2005-04-14 Department Of Biogenic Amines, Polish Academy Of Sciences Cells and methods useful in characterising the immunotoxic activity of xenobiotic substances
CN109073635A (en) * 2016-01-25 2018-12-21 豪夫迈·罗氏有限公司 Method for Assaying T Cell Dependent Bispecific Antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6964191A (en) * 1989-11-16 1991-06-13 Cornell Research Foundation Inc. Particle-mediated transformation of animal tissue cells
GB9113097D0 (en) * 1991-06-18 1991-08-07 Boehringer Ingelheim Int Chimeric gene
US6197925B1 (en) * 1991-08-22 2001-03-06 Sara Lee Corporation NF-AT polypeptides and polynucleotides
CA2114434A1 (en) * 1991-08-22 1993-03-04 William M. Flanagan Screening methods for immunosuppressive agents
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
CA2180526A1 (en) * 1994-01-05 1995-07-13 Joseph C. Hogan, Jr. Method of identifying chemical compounds having selected properties for a particular application
DE4447484C2 (en) * 1994-04-08 1997-07-17 Deutsches Krebsforsch Apoptosis inhibitor
US5807754A (en) * 1995-05-11 1998-09-15 Arqule, Inc. Combinatorial synthesis and high-throughput screening of a Rev-inhibiting arylidenediamide array
DE19534120A1 (en) * 1995-09-14 1997-03-20 Hoechst Ag Use of cytohesin PH peptides to influence the adhesiveness of integrins
WO1997040022A1 (en) * 1996-04-25 1997-10-30 T Cell Sciences, Inc. Immunosuppressive compounds from an arylidene diamide array

Also Published As

Publication number Publication date
WO1997039722A2 (en) 1997-10-30
WO1997039722A3 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
AU4770196A (en) Method for isolating dendritic cells
AU3356197A (en) Method of isolating cyclosporins
AU2079097A (en) Method and system for optimized scheduling
AU5493201A (en) Method for introduction of molecules into cells
AU1688695A (en) Adenoviral-mediated method of cell transfection
AU2247699A (en) Cell control method and apparatus
IL127912A0 (en) Method of activating dendritic cells
AU1496697A (en) Method of increasing testosterone
AU5893296A (en) Solar cell system and method of establishing the system
AU6228198A (en) Method of earthquake prediction
AU2311597A (en) Underwater installation and method for building of an underwater installation
AU7672296A (en) Method of preparing electrochemical cells
AUPO307196A0 (en) Method of controlled blasting
AU5116596A (en) Cell culture method
AU3324697A (en) Charging system and method
AU3661797A (en) Method for activation of bleaches
AU2814897A (en) Method of isolating regulators of t cell activation
AU7713896A (en) Method of producing an enterosorbent
AU4091897A (en) Solid state voltage regulator and methods therefore
AU2532295A (en) Method of genetic testing
AU3835697A (en) Method for inhibiting the growth of mammalian cells
AUPO235996A0 (en) Method of cell culture
AU1710095A (en) Method for isolating of wheyproteins
AU3990197A (en) Method of engraftment of cultured cells
AU3363595A (en) Method for isolating mutant cells